eletriptan has been researched along with sumatriptan in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (5.63) | 18.2507 |
2000's | 60 (84.51) | 29.6817 |
2010's | 7 (9.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hopkins, B; McHarg, A; Melrose, H; Napier, C; Stewart, M; Wallis, R | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Bell, IM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gupta, P; McHarg, A; Napier, C; Scatchard, J; Wallis, R | 1 |
Goadsby, PJ; Hoskin, KL | 1 |
Deleu, D; Hanssens, Y | 2 |
Ferrari, MD; Goadsby, PJ; Jackson, NC; Olesen, J; Poole, PH; Senard, JM; Stovner, LJ | 1 |
Butler, P; Gupta, P; McHarg, A; Shepperson, NB | 1 |
Palmer, JB; Salonen, R | 1 |
Spierings, EL | 1 |
Al-Shekhlee, A; Reed, R | 1 |
Avezaat, CJ; Bogers, AJ; de Vries, R; MaassenVanDenBrink, A; Saxena, PR; Stegmann, AP; van den Broek, RW | 1 |
Chadaide, Z; Csillik, AE; Knyihár-Csillik, E; Mihály, A; Tajti, J; Vécsei, L | 1 |
Avezaat, CJ; Bogers, AJ; de Vries, R; MaassenVanDenBrink, A; Saxena, PR; van den Broek, RW | 1 |
Lunte, CE; Saunders, K; Weiss, DJ | 1 |
Diener, HC; McHarg, A | 1 |
Chadaide, Z; Csillik, B; Knyihár-Csillik, E; Tajti, J; Vécsei, L | 1 |
Hashimoto, S; Iwata, M | 1 |
Fenvik, W; Humphrey, PP; Salonen, R | 1 |
Marcus, DA | 1 |
Einecke, D | 1 |
Johnson, DE; McHarg, AD; Rollema, H; Schmidt, AW | 1 |
Rapoport, AM; Tepper, SJ | 1 |
Freitag, FG | 1 |
Rapoport, AM; Sheftell, FD; Tepper, SJ | 1 |
Burgess, G; Färkkilä, M; Forster, E; Haughie, S; Sandrini, G | 1 |
Giffin, N | 1 |
Mathew, NT; Muirhead, N; Schoenen, J; Sikes, CR; Winner, P | 1 |
Adelman, JU; Lewit, EJ | 1 |
Dahlöf, C; Färkkilä, M; Muirhead, N; Olesen, J; Rasmussen, S; Sikes, C; Stovner, LJ; ter Bruggen, JP | 1 |
Allen, C; Evans, DC; Evers, R; Hargreaves, R; Lake, BG; O'Connor, D | 1 |
Dodick, DW | 1 |
Loftus, BD | 1 |
Kori, S; Richardson, MS; Salonen, R; Scott, A | 1 |
Kaniecki, RG | 1 |
Diener, HC; Hettiarachchi, J; Ryan, R; Sun, W | 1 |
Iizuka, T; Sakai, F | 1 |
Bigal, ME; Goadsby, PJ; Lipton, RB | 1 |
Jähnichen, S; Pertz, HH; Radtke, OA | 1 |
Dodick, DW; Papademetriou, V | 1 |
Gibson, M; Goldstein, JA; Hettiarachchi, J; Jackson, NC; Kirby, S; Massey, KD; Rankin, AJ | 1 |
Kato, K | 1 |
Manaka, S | 1 |
Kowa, H; Nakashima, K; Takeshima, T | 1 |
Igarashi, H | 1 |
Morillo, LE | 2 |
Hettiarachchi, J; Pascual, J; Rasmussen, S; Schoenen, J; Sikes, C; Sun, W | 1 |
Davenport, A; Edvinsson, L; Longmore, J; Malmsjö, M; Uddman, E; Wackenfors, A | 1 |
Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C | 1 |
Alderman, J; Cox, E; Mandema, JW | 1 |
Buller, N; Cumberland, D; Hettiarachchi, J; Hillis, WS; Kirby, S; Newman, CM; Seabra-Gomes, R; Starkey, I | 1 |
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L | 1 |
Mullins, CD; Pradel, FG; Subedi, P; Varghese, AA; Weis, KA | 1 |
Iversen, HK; Tfelt-Hansen, P | 1 |
Albert, KS; Almas, M; Diener, HC; Dodick, DW; Ferrari, MD; Goadsby, PJ; Lipton, RB; Parsons, B; Tfelt-Hansen, P | 1 |
Nahas, SJ; Silberstein, SD | 1 |
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP | 1 |
Kitagawa, Y; Suzuki, Y; Takayanagi, R; Tokuoka, K; Watanabe, M; Yamada, Y | 1 |
Han, W; Li, M; Wang, J; Xu, H | 1 |
Nguyen, D; Roberts, AG; Wilt, LA | 1 |
22 review(s) available for eletriptan and sumatriptan
Article | Year |
---|---|
Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
Topics: Amino Acid Sequence; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Drug Discovery; Humans; Migraine Disorders; Molecular Sequence Data; Receptors, Calcitonin Gene-Related Peptide; Structure-Activity Relationship | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
[Current topics: expectation for new triptans].
Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Triptans are all different.
Topics: Carbazoles; Headache; Humans; Indoles; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Acute treatment of migraine and the role of triptans.
Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Mechanisms of action of the 5-HT1B/1D receptor agonists.
Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2002 |
Eletriptan: pharmacological differences and clinical results.
Topics: Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2001 |
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Sumatriptan versus eletriptan: which is best?
Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines | 2002 |
[Recent progress in therapy for migraine headache].
Topics: Anticonvulsants; Botulinum Toxins; Calcitonin Gene-Related Peptide; Central Nervous System; Clinical Trials as Topic; Drug Design; Fructose; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Pain; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Topiramate; Triazoles; Trigeminal Nerve; Tryptamines; Vasodilation | 2004 |
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.
Topics: Administration, Oral; Analgesics; Double-Blind Method; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Tryptamines | 2004 |
[Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
Topics: Animals; Biological Availability; Cardiovascular System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2004 |
[Triptans in migraine: from clinical view].
Topics: Drug Administration Schedule; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2004 |
[Meta-analysis of triptan treatment in migraine].
Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
[Side effects of triptans].
Topics: Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sleep Stages; Sumatriptan; Triazoles; Tryptamines; Vomiting | 2004 |
Migraine headache.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Migraine headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines | 2004 |
Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
Topics: Capsules; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Models, Statistical; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2005 |
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
Topics: Acute Disease; Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2006 |
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2016 |
10 trial(s) available for eletriptan and sumatriptan
Article | Year |
---|---|
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vasoconstrictor Agents | 2000 |
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Topics: Adult; Double-Blind Method; Female; Humans; Indoles; Logistic Models; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Remission Induction; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2002 |
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.
Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2003 |
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Drug Tolerance; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Sumatriptan; Tryptamines | 2003 |
Effect of high-dose intravenous eletriptan on coronary artery diameter.
Topics: Adult; Confidence Intervals; Coronary Vessels; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Infusions, Intravenous; Male; Middle Aged; Pyrrolidines; Sumatriptan; Tryptamines; Vasoconstriction | 2004 |
Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan.
Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Female; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2005 |
Multiple attack study on the available triptans in Italy versus placebo.
Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2005 |
Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrrolidines; Sumatriptan; Tryptamines; Vasoconstrictor Agents; Vasodilation | 2005 |
Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Headache; Humans; Incidence; Male; Maryland; Middle Aged; Migraine Disorders; Outcome Assessment, Health Care; Patient Satisfaction; Pyrrolidines; Recovery of Function; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2006 |
Theory-based analysis of clinical efficacy of triptans using receptor occupancy.
Topics: Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2014 |
39 other study(ies) available for eletriptan and sumatriptan
Article | Year |
---|---|
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Topics: Animals; Binding, Competitive; Cell Line; Cold Temperature; COS Cells; HeLa Cells; Humans; Indoles; Kinetics; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Sumatriptan; Triazoles; Tritium; Tryptamines | 1999 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
Topics: Alkylation; Animals; Basilar Artery; Benzamides; Dogs; Female; In Vitro Techniques; Indoles; Male; Pyridines; Pyrrolidines; Receptors, Serotonin; Saphenous Vein; Serotonin Antagonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 1999 |
Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
Topics: Animals; Cats; Cranial Sinuses; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Indoles; Neurons; Proto-Oncogene Proteins c-fos; Pyrrolidines; Serotonin Receptor Agonists; Stimulation, Chemical; Sumatriptan; Trigeminal Neuralgia; Tryptamines; Vasoconstrictor Agents | 1999 |
The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Topics: Anesthesia; Animals; Blood Flow Velocity; Blood Proteins; Capillary Permeability; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Dura Mater; Electric Stimulation; Female; Femoral Artery; Hemodynamics; Indoles; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion; Tryptamines | 2000 |
Migraine revolution and sumatriptan.
Topics: Capsules; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Therapeutic Equivalency; Tryptamines | 2000 |
Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
Topics: Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2000 |
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
Topics: Acute Disease; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2000 |
Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.
Topics: Adult; Aged; Benzamides; Coronary Vessels; Female; Humans; Indoles; Male; Meningeal Arteries; Middle Aged; Pyridines; Pyrrolidines; Saphenous Vein; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2000 |
Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.
Topics: Animals; Axons; Brain; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Female; Gene Expression Regulation; Genes, fos; Genes, jun; Indoles; Male; Migraine Disorders; Neurons, Afferent; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Pyrrolidines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Spinal Cord; Sumatriptan; Trigeminal Ganglion; Tryptamines | 2000 |
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels.
Topics: Aged; Blood Vessels; Brain; Cerebrovascular Circulation; Female; Humans; Indoles; Kinetics; Male; Middle Aged; Muscle Contraction; Pyrrolidines; Sumatriptan; Tryptamines | 2000 |
pH-mediated field-amplified sample stacking of pharmaceutical cations in high-ionic strength samples.
Topics: Cations; Doxazosin; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Indoles; Isotonic Solutions; Osmolar Concentration; Phenethylamines; Piperazines; Purines; Pyrimidinones; Pyrrolidines; Ringer's Solution; Sildenafil Citrate; Sulfonamides; Sulfones; Sumatriptan; Tryptamines | 2001 |
Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
Topics: Double-Blind Method; Female; Humans; Indoles; Male; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2000 |
Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
Topics: Animals; Capillaries; Dura Mater; Electric Stimulation; Female; Immunohistochemistry; Indoles; Male; Microscopy, Electron; Migraine Disorders; Nerve Endings; Nerve Fibers; Neuropeptides; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Pyrrolidines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion; Tryptamines; Vasoconstrictor Agents | 2001 |
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels.
Topics: Blood Vessels; Cerebrovascular Circulation; Humans; In Vitro Techniques; Indoles; Pyrrolidines; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2001 |
[New potent serotonin receptor agonist. Helps migraine patients even when other triptans fail].
Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2001 |
Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
Topics: Animals; Binding, Competitive; Brain; Cattle; Cerebral Cortex; Dose-Response Relationship, Drug; Extracellular Space; Indoles; Injections, Intravenous; Membranes; Microdialysis; Oxazolidinones; Pyridines; Pyrrolidines; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines | 2001 |
[New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain].
Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2002 |
[Migraine has to be treated. Otherwise a stroke threatens].
Topics: Humans; Indoles; Migraine Disorders; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Stroke; Sumatriptan; Time Factors; Tryptamines | 2002 |
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Topics: Area Under Curve; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Therapeutic Equivalency; Tryptamines; Vasoconstrictor Agents | 2003 |
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Genes, MDR; Humans; Indoles; Injections, Intravenous; Male; Mice; Mice, Mutant Strains; Miconazole; Microsomes, Liver; Oxazolidinones; Oxidoreductases, N-Demethylating; Phenotype; Piperidines; Pyrrolidines; Recombinant Proteins; Statistics as Topic; Sumatriptan; Triazoles; Troleandomycin; Tryptamines | 2003 |
Unilateral time-delayed encapsulation does not make for a fair race.
Topics: Capsules; Delayed-Action Preparations; Double-Blind Method; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2003 |
[Strong and sustained-acting triptan. Therewith migraine does not return soon].
Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Placebos; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents | 2003 |
Encapsulated sumatriptan is not bioequivalent to commercial sumatriptan.
Topics: Capsules; Humans; Indoles; Pyrrolidines; Research Design; Serotonin Receptor Agonists; Sumatriptan; Therapeutic Equivalency; Tryptamines | 2003 |
Musing on Mathew et al.
Topics: Capsules; Clinical Trials as Topic; Double-Blind Method; Humans; Indoles; Migraine Disorders; Prospective Studies; Pyrrolidines; Research Design; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2003 |
[Improved pharmacokinetics. Fast tryptan with sustained response].
Topics: Administration, Oral; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; Headache; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Placebos; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Tryptamines | 2003 |
[Highly selective beginning. Associated symptoms and side effects in retrospect].
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg.
Topics: Adolescent; Adult; Aged; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Odds Ratio; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Tryptamines | 2004 |
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Topics: Animals; Benzamides; Brain; Carbazoles; Dinoprost; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Forecasting; Guinea Pigs; Iliac Artery; Indoles; Ketanserin; Male; Muscle Contraction; Muscle, Smooth; Oxadiazoles; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
Cardiovascular safety of triptans.
Topics: Cardiovascular Diseases; Humans; Indoles; Pyrrolidines; Sumatriptan; Tryptamines | 2004 |
[Use of triptanes according to indications. Risk of infarct is not increased].
Topics: Cerebral Infarction; Clinical Trials as Topic; Coronary Circulation; Humans; Indoles; Injections, Intravenous; Injections, Subcutaneous; Migraine Disorders; Myocardial Infarction; Pyrrolidines; Risk; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Topics: Adult; Cerebral Arteries; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System | 2005 |
[Medical treatment of migraine attacks in the child].
Topics: Acetaminophen; Age Factors; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Ergot Alkaloids; Humans; Ibuprofen; Life Style; Migraine Disorders; Oxazolidinones; Parents; Patient Education as Topic; Pediatrics; Piperidines; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Taste Disorders; Triazoles; Tryptamines; Vasoconstrictor Agents | 2006 |
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
Topics: Adolescent; Adult; Age Factors; Aged; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Predictive Value of Tests; Pyrrolidines; Randomized Controlled Trials as Topic; Secondary Prevention; Serotonin Receptor Agonists; Sex Factors; Sumatriptan; Tryptamines | 2008 |
Triptans: actions and reactions.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Migraine Disorders; Neuralgia, Postherpetic; Pyrrolidines; Serotonin Receptor Agonists; Skin; Sumatriptan; Tryptamines | 2008 |
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines | 2010 |
Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.
Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Hydrolysis; Mice; Protein Conformation; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2017 |